Search for " " - 2/181

Results for “ ”

Entry	Author	Date	Location
Bio Roundup: So Long Celgene, RNAi’s Arrival, Pharma in 2020 & More	Frank Vinluan	11/22/19	National
Biopharma Execs Remain Optimistic Despite Political Headwinds	Mike Ward	11/20/19	National
With “Inflection Year” Ahead, Ovid Adds Novartis’s Tardio to C-Suite	Sarah de Crescenzo	11/18/19	New York
Alkermes Eyes Brain Disorders and Beyond With $100M Deal for Rodin	Frank Vinluan	11/18/19	Boston
Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More	Sarah de Crescenzo	11/15/19	National
Daré to Add Microchip-Based Birth Control to Women’s Health Portfolio	Sarah de Crescenzo	11/15/19	San Diego
FDA Again Halts Solid Bio’s Duchenne Gene Therapy Clinical Trial	Frank Vinluan	11/12/19	Boston
Roche Challenger to Biogen’s SMA Drug Succeeds in Pivotal Study	Frank Vinluan	11/11/19	National
Neuroscience Is Taking the Spotlight at Xconomy’s Bay Area Xchange	Frank Vinluan	11/11/19	San Francisco
Looking to Level Up in NASH, Novo Nordisk Licenses Ube Drug Candidate	Sarah de Crescenzo	11/08/19	National
Anemia Drug From Acceleron Pharma and Celgene Wins FDA Approval	Frank Vinluan	11/08/19	New York
Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More	Frank Vinluan	11/08/19	National
AstraZeneca Chooses China for R&D and AI Centers, $1B Biotech Fund	Gareth Macdonald	11/06/19	National
GE Healthcare Opens Startup Labs at Former AstraZeneca UK R&D Site	Dan Stanton	11/06/19	National
Halozyme to Restructure After Pancreatic Cancer Drug Fails in Phase 3	Frank Vinluan	11/04/19	San Diego
Biotech Roundup: Novartis on Hold, AMAG Vote, Neuro News & More	Frank Vinluan	11/01/19	National
FDA Halts Novartis Gene Therapy Study Amid Animal Safety Concerns	Frank Vinluan	10/30/19	National
With Ex-Medivation Exec Hung at Helm, Nuvation Nabs $275M for Cancer	Frank Vinluan	10/28/19	New York
Bio Roundup: Biogen’s Reversal, FDA Moves Fast, a CF Cocktail & More	Sarah de Crescenzo	10/25/19	National
Acorda Cuts Staff 25% and Restructures to Keep Focus on Parkinson’s Drug	Frank Vinluan	10/24/19	New York
Biogen Reverses Course on Alzheimer’s Drug Analysis, Plans FDA Filing	Sarah de Crescenzo	10/22/19	Boston
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More	Frank Vinluan	10/18/19	National
Healx Bags $56M to Advance Affordable, AI-Based Orphan Drugs	Mike Ward	10/17/19	National
Alexion to Buy Achillion in $930M Marriage of Rare Disease Drug Firms	Frank Vinluan	10/16/19	Boston
Led by Gilead Veteran Riva, Glenmark’s Ichnos Steps Out on Its Own	Sarah de Crescenzo	10/15/19	New York
Bio Roundup: Nobel Prizes, Placebo Effect Rises, ICER’s Fire & More	Alex Lash	10/11/19	National
The Placebo Effect Is Hobbling New Psychiatric Drugs. What Can Stop It?	Alex Lash	10/10/19	National
Five Years After Y Combinator First Admits Biotechs, They’re Dug In	Bernadette Tansey	10/09/19	San Francisco
Catch Duchenne Patient Power, Phil Sharp & More Next Week at The Broad	Ben Fidler	10/08/19	Boston
Nobel Prize in Medicine Goes to 3 Who Showed How Cells Sense Oxygen Levels	Frank Vinluan	10/07/19	National
Page 2 of 150	« previous page · next page »

Underwriters and Partners

Xpertise: Watch + Learn

Sponsored · Whitepaper
What’s Next in Neuroscience Therapies
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders

Xconomy Insight · Special Report
How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook
Insights, wisdom, and inspiration on what it takes